Related Experiment Video
Updated: Feb 22, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
CMIP is oncogenic in human gastric cancer cells
Jianlin Zhang1, Jin Huang2, Xingyu Wang1
1Department of Emergency Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China.
Abstract:
Gastric cancer is one of the most common cancers and the second leading cause of cancer‑associated mortality worldwide. Recurrence, metastasis and resistance to drug treatment are the main barrier to survival of patients with advanced stage gastric cancer. Further study of the molecular mechanisms involved will improve the therapeutic options for gastric cancer. In a previous study, c‑Maf was discovered as an oncogene transduced in the avian AS42 retrovirus, and was found to be overexpressed in multiple myeloma and angioimmunoblastic T‑cell lymphoma. c‑Maf inducing protein (CMIP) is involved in the c‑Maf signaling pathway, which was reported to serve an important role in human minimal change nephrotic syndrome and in human reading and language related behavior. However, the relationship between CMIP and human gastric cancer has not yet been reported. In the present study, CMIP protein levels in gastric cancer tissues and cells were measured using immunohistochemistry and western blot analysis; the expression of CMIP protein was significantly higher in gastric cancer tissues compared with normal gastric tissues. Expression was positively associated with poorer clinical parameters, relapse‑free survival and overall survival. Furthermore, using cell counting, Cell Counting Kit‑8, colony formation, wound healing and Transwell assays, together with flow cytometry, CMIP depletion by RNA interference was observed to reduce the capacity of gastric cancer cells to proliferate and migrate in vitro. Furthermore, the upstream and downstream genes of CMIP were analyzed by luciferase reporter assay and reverse transcription quantitative polymerase chain reaction, which indicated that CMIP was a direct target of miR‑101‑3p. In addition, CMIP knockdown was observed to result in the downregulation of MDM2 and mitogen activated protein kinase (MAPK) expression at the mRNA level. In conclusion, CMIP demonstrated an oncogenic role in human gastric cancer cells. Furthermore, microRNA‑101‑3p, MDM2 and MAPK were involved in the CMIP signaling pathway in gastric cancer. CMIP could be a novel target for further investigation in the clinical therapeutic management of gastric cancer.
Insights
c-Maf inducing protein (CMIP) drives gastric cancer growth and spread. Lowering CMIP levels inhibited cancer cell proliferation and migration, suggesting CMIP as a potential therapeutic target for gastric cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Gastric cancer is a leading cause of cancer mortality worldwide.
- Recurrence, metastasis, and drug resistance impede survival in advanced gastric cancer.
- Understanding molecular mechanisms is crucial for improving gastric cancer therapeutics.
Purpose of the Study:
- To investigate the role of c-Maf inducing protein (CMIP) in human gastric cancer.
- To explore the relationship between CMIP expression and clinical parameters, survival, and cellular behavior.
- To elucidate the molecular pathways involving CMIP in gastric cancer.
Main Methods:
- Immunohistochemistry and western blot analysis to assess CMIP protein levels.
- In vitro assays (cell counting, CCK-8, colony formation, wound healing, Transwell) to evaluate CMIP's effect on cell proliferation and migration.
- RNA interference (RNAi) for CMIP depletion.
- Luciferase reporter assay and RT-qPCR to analyze upstream and downstream gene regulation.
Main Results:
- CMIP protein expression was significantly elevated in gastric cancer tissues compared to normal tissues.
- Higher CMIP expression correlated with poorer clinical parameters, relapse-free survival, and overall survival.
- CMIP depletion reduced gastric cancer cell proliferation and migration in vitro.
- CMIP was identified as a direct target of miR-101-3p.
- CMIP knockdown led to downregulation of MDM2 and MAPK mRNA expression.
Conclusions:
- CMIP exhibits an oncogenic role in human gastric cancer.
- CMIP, miR-101-3p, MDM2, and MAPK are involved in a critical signaling pathway in gastric cancer.
- CMIP represents a potential novel therapeutic target for gastric cancer management.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
09:16Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
Published on: February 5, 2018
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Mitogens and the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...